Medical Marijuana I Stock Fundamentals

MJNA Stock  USD 0.0004  0.0001  33.33%   
Medical Marijuana I fundamentals help investors to digest information that contributes to Medical Marijuana's financial success or failures. It also enables traders to predict the movement of Medical Pink Sheet. The fundamental analysis module provides a way to measure Medical Marijuana's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Medical Marijuana pink sheet.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Medical Marijuana I Company Return On Asset Analysis

Medical Marijuana's Return on Asset or ROA shows how effective is the management of the company in generating income from utilizing all of the assets at their disposal. It is a useful ratio to evaluate the performance of different departments of a company as well as to understand management performance over time.

Return On Asset

 = 

Net Income

Total Assets

More About Return On Asset | All Equity Analysis

Current Medical Marijuana Return On Asset

    
  -0.0146  
Most of Medical Marijuana's fundamental indicators, such as Return On Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Medical Marijuana I is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Return on Asset measures overall efficiency of a company in generating profits from its total assets. It is expressed as the percentage of profits earned per dollar of Asset. A low ROA typically means that a company is asset-intensive and therefore will needs more money to continue generating revenue in the future.
Competition

Based on the latest financial disclosure, Medical Marijuana I has a Return On Asset of -0.0146. This is 99.83% lower than that of the Health Care Providers & Services sector and significantly lower than that of the Health Care industry. The return on asset for all United States stocks is 89.57% lower than that of the firm.

Medical Marijuana Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Medical Marijuana's current stock value. Our valuation model uses many indicators to compare Medical Marijuana value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Medical Marijuana competition to find correlations between indicators driving Medical Marijuana's intrinsic value. More Info.
Medical Marijuana I is considered to be number one stock in return on equity category among its peers. It also is considered to be number one stock in return on asset category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Medical Marijuana by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Medical Marijuana's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Medical Return On Asset Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Medical Marijuana's direct or indirect competition against its Return On Asset to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Medical Marijuana could also be used in its relative valuation, which is a method of valuing Medical Marijuana by comparing valuation metrics of similar companies.
Medical Marijuana is currently under evaluation in return on asset category among its peers.

Medical Fundamentals

About Medical Marijuana Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Medical Marijuana I's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Medical Marijuana using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Medical Marijuana I based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Medical Marijuana, Inc., an investment holding company, operates in the cannabinoid-based nutraceutical industry. Medical Marijuana, Inc. was incorporated in 2005 and is based in San Diego, California. Medical Marijuana operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 91 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Medical Pink Sheet

Medical Marijuana financial ratios help investors to determine whether Medical Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medical with respect to the benefits of owning Medical Marijuana security.